Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis? - Wikidata - awgldk - TriplyDB

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

http://www.wikidata.org/entity/Q42406664

about

Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis.Idiopathic pulmonary fibrosis: early detection and referral.A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?

P2860

Q33631115-D33400CE-0760-413E-9AF1-CC1BAF7ACA66 Q38205617-74500BCF-E246-49C3-AD78-8681209EBC64 Q45293217-F12F137F-BE6B-44B3-961E-4CAFAEAA439A

P2860

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

http://www.wikidata.org/entity/Q42406664

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@en

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@nl

type

label

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@en

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@nl

prefLabel

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@en

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@nl

P1433

Q42406664-4E993282-B0DD-4DBD-ACF7-D2522250AC47

P1476

Q42406664-CA22444D-1EA1-473F-86CE-3D7F5BA60B7F

P2093

Q42406664-44FC1173-ED24-43A6-967A-941C560B0384

Q42406664-B7ED68F0-AB09-4EFD-84DB-D51F7711E73B

P2860

Q42406664-03FDCAE5-1555-4D21-A59F-9B2C242B7E8F

Q42406664-0EBA98A2-5FB9-4042-8559-3F506D968716

Q42406664-1B869B51-9995-495B-92F1-555A6E614B84

Q42406664-373DA8B6-F418-470D-AE70-3590567A55E7

Q42406664-488CB5F5-509A-4341-A824-FDE874C2D352

Q42406664-5C15C6BE-2A36-436F-9A3E-A411A4A11FF8

Q42406664-66CC1F2A-4CF6-473D-A562-FCF50520589B

Q42406664-696BA670-11B0-4B94-8D0E-817BFC3332B1

Q42406664-7633393F-537C-4E86-B96F-FC5FDB878616

Q42406664-A25F9ABA-B632-4696-A0C2-BB3FBEC13FDE

P304

Q42406664-F6C96D79-CBD4-49C9-92E7-E9788F9EEA35

P31

Q42406664-8C262C24-17AD-4710-B713-FA4909610675

P356

Q42406664-0351272D-2B5F-4072-8135-10337EFCDA6C

P407

Q42406664-81E4AF8D-66F7-47E0-974F-0C026D0E14AA

P433

Q42406664-A913F3E3-E57B-4D10-839A-46BFDD1AC08A

P478

Q42406664-5C0C056E-8618-4FA5-821D-378A3BE88CE7

P577

Q42406664-3FAA4477-14E8-431B-B827-915696DA1472

P698

Q42406664-826D047B-F8D6-48B4-912C-A6575F75814B

P921

Q42406664-13C52117-F087-4DE7-8677-FEEAADEAF95C

Q42406664-4F82CFB0-38B1-4AA7-91A7-A40E25538C3D

P932

Q42406664-98636AE9-B470-4CA2-8D37-F038357895D1

P356

AJRCCM.186.7.693

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?

@en

P2093

Elisabeth Bendstrup

http://www.w3.org/2001/XMLSchema#string

Ole Hilberg

http://www.w3.org/2001/XMLSchema#string

P2860

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis

Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.

Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells.

Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.

Non-anticoagulant effects of heparin: an overview.

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.

Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung.

Anticoagulant therapy for idiopathic pulmonary fibrosis.

Effect of inhaled heparin on lung function and coagulation in healthy volunteers.

P304

693; author reply 693-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.186.7.693

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23027854

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

anticoagulation

P932

3480518

http://www.w3.org/2001/XMLSchema#string